Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$4.66
Change (%) Stock is Up 0.38 (8.88%)
Volume39,842
Data as of 10/22/14 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
10/22/14Bacterin Presents Preclinical Results of an Efficacious Antimicrobial Orthopedic Device Coating
BELGRADE, Mont., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, presented preclinical results of a robust and efficacious antimicrobial coating for orthopedic hardware at the 2014 Orthopaedic Trauma Association (OTA) Annual Meeting. The coating is intended to address one of the most serious complications in orthopedic surgery, implant-associated infections. Of t... 
Printer Friendly Version
10/20/14Bacterin Announces 3Demin(TM) Cortical Fibers
BELGRADE, Mont., Oct. 20, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the launch of a demineralized allograft, 3Demin™ Cortical Fibers. 3Demin™ Cortical Fibers are the first product released in Bacterin's latest 3Demin™ product family, and the second new product launched this year. 3Demin™ allografts may be used in a number of orthopedic and reconstruc... 
Printer Friendly Version
10/16/14CORRECTING AND REPLACING -- Bacterin Announces Preliminary Third Quarter 2014 Revenue
Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In a release issued on Tuesday, October 14th 2014 by Bacterin International Holdings, Inc. (NYSE MKT:BONE), there was an error in the third paragraph. Please note that the final sentence of the third paragraph should read, "We are now starting to realize the benefits of these investments and... 
Printer Friendly Version
10/16/14Bacterin International Announces Sales Team Expansion
Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Bacterin announced today three senior executive additions to its hybrid sales channel. Jeff Whitaker has joined us as Regional Vice President in the Southeast, he brings a track record of success at Stryker Biotech, Mitek Surgical Products (DePuy), and Acufex Microsurgical, Inc. Doug Helling has joined us as Regional Vice President in the South (Texas, Oklahoma), he brings a track r... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.